1.Assessment of myocardial perfusion status through the angiographically visible collaterals in the ischemic heart disease.
Byung Hoe KIM ; Eung Ju KIM ; Seung Jin LEE ; Jeong Cheon AHN ; Woo Hyug SONG ; Do Sun LIM ; Chang Gyu PARK ; Young Hoon KIM ; Hong Seog SEO ; Wan Joo SHIM ; Dong Joo OH ; Young Moo RO
Korean Circulation Journal 1998;28(3):350-358
BACKGROUND: It is well known that collateral circulation has important roles in ischemic heart diseases. The method most commonly used at present to evaluate collateral flow is coronary angiography. However, there are debates about the functional significance of angiographically visible collaterals because angiography visualizes only vessels that are larger than 100um in diameter. Recent studies suggest that myocardial contrast echocardiography (MCE) is a useful method in assessing collateral flow because it uses small microvascular tracers (4-12um) as a contrast agent. By using MCE, this study evaluates the role of angiographically visible collaterals in patients with acute myocardial infarction (AMI) and chronic ischemic heart disease. METHOD: Forty-one patients who underwent coronary angiography and MCE were included in this study (22 patients with acute myocardial infarction and 19 patients with chronic ischemic heart disease). Antegrade coronary flow was less than TIMI 3 flow in all patients. Myocardial perfusion through collaterals with MCE was evaluated by injecting sonicated Hexabrix into nonobstructing coronary arteries. Angiographically visualized collateral vessels were analysed as four grades and compared with the degree of myocardial opacification by MCE through collateral vessels. RESULT: Angiographic collaterals were frequently observed in patients with AMI and chronic ischemic heart disease with< or = TIMI 2 flow . There was poor correlation between TIMI grade and the grade of collaterals by angiography in AMI (r--0.29, p-0.20) and chronic ischemic heart disease (r--0.31, p-0.19). There was no correlation between collateral grades and myocardial opacification by MCE through collateral vessels in AMI (r-0.07, p-NS) and chronic ischemic heart disease (r-0.10, p-NS). In patients with relatively well developed collaterals (Grade II or III), the ischemic zone was perfused better through collateral flow in the chronic ischemic heart disease group than in the AMI group (Mean Retrograde Opacification Index 0.84+/-0.23 vs 0.32+/-0.22, p<0A65A>0.05). CONCLUSION: The study suggests that the role of angiographically visible collaterals is different in chronic ischemic heart disease and acute myocardial infarction. The grade of angiographically visible collaterals does not imply the extent of perfusion to myocardum at risk through collateral vessels.
Angiography
;
Collateral Circulation
;
Coronary Angiography
;
Coronary Vessels
;
Echocardiography
;
Heart
;
Humans
;
Ioxaglic Acid
;
Myocardial Infarction
;
Myocardial Ischemia*
;
Perfusion*
2.Regression of Russell Body Gastritis after Helicobacter pylori Eradication.
Jin Seo LEE ; Eun Ju KIM ; Se Jeong PARK ; Kwang Woo NAM ; Seung Hyeon BAE ; Eun Jin KIM ; Ho June SONG ; Gin Hyug LEE ; Hwoon Yong JUNG ; Jin Ho KIM
The Korean Journal of Helicobacter and Upper Gastrointestinal Research 2013;13(3):189-193
Russell body gastritis is a very rare gastric inflammatory lesion, which presents as dense infiltration of plasma cells containing immunoglobulin structures of Russell body. The lesion is closely associated with Helicobacter pylori-induced chronic gastritis and mimics malignant tumors, such as marginal zone B-cell lymphoma of mucosa-associated lymphoid tissues and signet-ring cell carcinoma. We report a case of Russell body gastritis which regressed 6 months after eradication of H. pylori. Herein we described endoscopic features of Russell body gastritis and histological details of differential diagnosis.
Diagnosis, Differential
;
Gastritis
;
Helicobacter
;
Helicobacter pylori
;
Immunoglobulins
;
Lymphoid Tissue
;
Lymphoma, B-Cell, Marginal Zone
;
Plasma Cells
3.Erythromycin infusion prior to endoscopy for acute nonvariceal upper gastrointestinal bleeding: a pilot randomized controlled trial.
Hee Kyong NA ; Hwoon Yong JUNG ; Dong Woo SEO ; Hyun LIM ; Ji Yong AHN ; Jeong Hoon LEE ; Do Hoon KIM ; Kee Don CHOI ; Ho June SONG ; Gin Hyug LEE ; Jin Ho KIM
The Korean Journal of Internal Medicine 2017;32(6):1002-1009
BACKGROUND/AIMS: The aim of this study was to compare the effects of erythromycin infusion and gastric lavage in order to improve the quality of visualization during emergency upper endoscopy. METHODS: We performed a prospective randomized pilot study. Patients presented with hematemesis or melena within 12 hours and were randomly assigned to the erythromycin group (intravenous infusion of erythromycin), gastric lavage group (nasogastric tube placement with gastric lavage), or erythromycin + gastric lavage group (both erythromycin infusion and gastric lavage). The primary outcome was satisfactory visualization. Secondary outcomes included identification of a bleeding source, the success rate of hemostasis, duration of endoscopy, complications related to erythromycin infusion or gastric lavage, number of transfused blood units, rebleeding rate, and bleeding-related mortality. RESULTS: A total of 43 patients were randomly assigned: 14 patients in the erythromycin group; 15 patients in the gastric lavage group; and 14 patients in the erythromycin + gastric lavage group. Overall satisfactory visualization was achieved in 81% of patients: 92.8% in the erythromycin group; 60.0% in the gastric lavage group; and 92.9% in the erythromycin + gastric lavage group, respectively (p = 0.055). The identification of a bleeding source was possible in all cases. The success rate of hemostasis, duration of endoscopy, and number of transfused blood units did not significantly differ between groups. There were no complications. Rebleeding occurred in three patients (7.0%). Bleeding-related mortality was not reported. CONCLUSIONS: Intravenous erythromycin infusion prior to emergency endoscopy for acute nonvariceal upper gastrointestinal bleeding seems to provide satisfactory endoscopic visualization.
Emergencies
;
Endoscopy*
;
Erythromycin*
;
Gastric Lavage
;
Gastrointestinal Hemorrhage
;
Hematemesis
;
Hemorrhage*
;
Hemostasis
;
Humans
;
Melena
;
Mortality
;
Pilot Projects
;
Prospective Studies
4.A Case of Enteropathy-associated T-cell Lymphoma Presenting with Recurrent Hematochezia.
Dong Hoon YANG ; Seung Jae MYUNG ; Hye Sook CHANG ; Jin Woo SONG ; Suk Kyun YANG ; Gin Hyug LEE ; Hwoon Yong JUNG ; Weon Seon HONG ; Jin Ho KIM ; Young Il MIN ; Hee Cheol KIM ; Jooryung HUH ; Heung Bum OH
The Korean Journal of Gastroenterology 2003;42(6):527-532
Enteropathy-associated T-cell lymphoma (EATL) is an unusual primary gastrointestinal lymphoma, particularly associated with celiac sprue. This tumor usually affects the jejunum and grossly presents as multiple circumferential ulcers without the formation of definite tumor masses. Moreover, mesenteric lymph nodes are commonly involved. The patients have typically suffered from abdominal pain, diarrhea, or weight loss whereas some patients may manifest with nonspecific symptoms for a period of years or an acute emergency of perforation, obstruction, or hemorrhage. The clinical course of EATL is very unfavorable and the prognosis is poor. Both celiac sprue and EATL are very rare diseases in Asia, except India and Middle East. We report a 60-year-old male diagnosed as having EATL after segmental small bowel resection, who presented with recurrent gastrointestinal bleeding.
Celiac Disease/*complications
;
Gastrointestinal Hemorrhage/*etiology
;
Humans
;
Intestinal Neoplasms/complications/*diagnosis/pathology
;
Intestine, Small/pathology
;
Lymphoma, T-Cell/complications/*diagnosis/pathology
;
Male
;
Middle Aged
;
Recurrence